COVID-19 and cerebrovascular diseases: a comprehensive overview

Neurological manifestations are not uncommon during infection with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A clear association has been reported between cerebrovascular disease and coronavirus disease 2019 (COVID-19). However, whether this association is causal or inc...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Therapeutic advances in neurological disorders Ročník 13; s. 1756286420978004
Hlavní autoři: Tsivgoulis, Georgios, Palaiodimou, Lina, Zand, Ramin, Lioutas, Vasileios Arsenios, Krogias, Christos, Katsanos, Aristeidis H., Shoamanesh, Ashkan, Sharma, Vijay K., Shahjouei, Shima, Baracchini, Claudio, Vlachopoulos, Charalambos, Gournellis, Rossetos, Sfikakis, Petros P., Sandset, Else Charlotte, Alexandrov, Andrei V., Tsiodras, Sotirios
Médium: Journal Article
Jazyk:angličtina
Vydáno: London, England SAGE Publications 2020
SAGE PUBLICATIONS, INC
SAGE Publishing
Témata:
ACE2
Angiotensin
Angiotensin-converting enzyme 2
Case reports
Cerebrovascular disease
Cerebrovascular diseases
Coronaviridae
Coronaviruses
COVID-19
Embolism
Hemorrhage
Ischemia
Laboratories
Peptidyl-dipeptidase A
Review
Severe acute respiratory syndrome coronavirus 2
Stroke
Thrombosis
Vascular diseases
COVID-19
SARS-CoV-2
cerebrovascular disease
stroke
ISSN:1756-2864, 1756-2856, 1756-2864
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Neurological manifestations are not uncommon during infection with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A clear association has been reported between cerebrovascular disease and coronavirus disease 2019 (COVID-19). However, whether this association is causal or incidental is still unknown. In this narrative review, we sought to present the possible pathophysiological mechanisms linking COVID-19 and cerebrovascular disease, describe the stroke syndromes and their prognosis and discuss several clinical, radiological, and laboratory characteristics that may aid in the prompt recognition of cerebrovascular disease during COVID-19. A systematic literature search was conducted, and relevant information was abstracted. Angiotensin-converting enzyme-2 receptor dysregulation, uncontrollable immune reaction and inflammation, coagulopathy, COVID-19-associated cardiac injury with subsequent cardio-embolism, complications due to critical illness and prolonged hospitalization can all contribute as potential etiopathogenic mechanisms leading to diverse cerebrovascular clinical manifestations. Acute ischemic stroke, intracerebral hemorrhage, and cerebral venous sinus thrombosis have been described in case reports and cohorts of COVID-19 patients with a prevalence ranging between 0.5% and 5%. SARS-CoV-2-positive stroke patients have higher mortality rates, worse functional outcomes at discharge and longer duration of hospitalization as compared with SARS-CoV-2-negative stroke patients in different cohort studies. Specific demographic, clinical, laboratory and radiological characteristics may be used as ‘red flags’ to alarm clinicians in recognizing COVID-19-related stroke.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1756-2864
1756-2856
1756-2864
DOI:10.1177/1756286420978004